Text Size
6 studies found for:    "methodist hospital" AND ebv-specific cytotoxic t-lymphocyte | Open Studies | United States, Texas | Houston

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel;   Drug: Carboplatin;   Drug: Dexamethasone;   Biological: EBV-specific cytotoxic T lymphocytes
2 Recruiting Safety Study of Injections of Autologous/Allogeneic TGFbeta-resistant LMP2A-specific Cytotoxic T-lymphocytes (CTL)
Conditions: Lymphoma;   Hodgkin's Disease;   Relapse;   Lymphoma, Non-Hodgkin
Intervention: Genetic: TGF-b Resistant LMP2A-Specific Cytotoxic T-Lymphocytes
3 Recruiting Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
Condition: Epstein-Barr Virus Infections
Intervention: Biological: EBV specific T cells
4 Recruiting EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Intervention: Genetic: autologous CAR.CD30 EBV specific-CTLs
5 Recruiting Study of the T-cells or EBV Specific CTLs for Advanced B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia
Intervention: Genetic: autologous or syngeneic PBTLs and EBV-CTLs
6 Recruiting Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy
Condition: HER2 Positive Malignancies
Intervention: Genetic: TGFBeta resistant HER2/EBV-CTLs
To Top

† Indicates status has not been verified in more than two years